Geode Capital Management’s Vivos Therapeutics VVOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
57,902
+553
| +1% | +$1.75K | ﹤0.01% | 3902 |
|
|
2025
Q1 | $163K | Buy |
57,349
+12,522
| +28% | +$35.7K | ﹤0.01% | 3903 |
|
|
2024
Q4 | $192K | Buy |
44,827
+16,025
| +56% | +$68.7K | ﹤0.01% | 3920 |
|
|
2024
Q3 | $75.2K | Buy |
28,802
+8,111
| +39% | +$21.2K | ﹤0.01% | 4171 |
|
|
2024
Q2 | $45.9K | Buy |
+20,691
| New | +$45.9K | ﹤0.01% | 4298 |
|
|
2023
Q4 | – | Sell |
-201,941
| Closed | -$38.8K | – | 4684 |
|
|
2023
Q3 | $38.8K | Hold |
201,941
| – | – | ﹤0.01% | 4480 |
|
|
2023
Q2 | $103K | Hold |
201,941
| – | – | ﹤0.01% | 4322 |
|
|
2023
Q1 | $68.9K | Hold |
201,941
| – | – | ﹤0.01% | 4446 |
|
|
2022
Q4 | $81K | Sell |
201,941
-464
| -0.2% | -$186 | ﹤0.01% | 4466 |
|
|
2022
Q3 | $131K | Hold |
202,405
| – | – | ﹤0.01% | 4433 |
|
|
2022
Q2 | $261K | Buy |
202,405
+657
| +0.3% | +$847 | ﹤0.01% | 4111 |
|
|
2022
Q1 | $540K | Buy |
201,748
+90,285
| +81% | +$242K | ﹤0.01% | 3896 |
|
|
2021
Q4 | $250K | Buy |
111,463
+37,612
| +51% | +$84.4K | ﹤0.01% | 4385 |
|
|
2021
Q3 | $298K | Buy |
73,851
+26,190
| +55% | +$106K | ﹤0.01% | 4273 |
|
|
2021
Q2 | $235K | Buy |
47,661
+35,281
| +285% | +$174K | ﹤0.01% | 4276 |
|
|
2021
Q1 | $82K | Buy |
+12,380
| New | +$82K | ﹤0.01% | 4335 |
|